Showing 811-820 of 9340 results for "".
Top 2023 Psoriasis Treatment Announcements
https://practicaldermatology.com/topics/psoriasis/top-2023-psoriasis-treatment-announcements/20232/Daniel Schlessinger, MD, Mohs Micrographic Surgery and Cosmetic Dermatology Fellow at Northwestern University, reviews for Practical Dermatology® some of the important psoriasis drug approval news of 2023.DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologiAtopic Dermatitis in the Spotlight: Uncovering the Burden Beneath the Skin?
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-in-the-spotlight-uncovering-the-burden-beneath-the-skin/20030/Highlighting the common symptoms experienced by patients and their perceived burden (including itch, lesions, pain and sleep disturbance), the impact of symptoms and particularly sleep disturbance on quality of life, activity, and mental health and the different atopic dermatitis phenotypes and relaAll Dressed Up: Optimal Wound Control to Reduce Scars
https://practicaldermatology.com/topics/skin-cancer-photoprotection/all-dressed-up-optimal-wound-control-to-reduce-scars/20022/Performing more than 25 million surgical procedures each year, dermatologists have the potential to create innumerable scars. Mara Weinstein Velez, MD talks about the best dressings to use to reduce the risk of scars and offers a look at laser-assisted drug delivery to address existing scars.Scientifically Speaking: Advances in Microneedling
https://practicaldermatology.com/videos/scientifically-speaking/scientifically-speaking-advances-in-microneedling/20012/Anna Guanche, MD; Mara Weinstein Velez, MD; and Doris Day, MD discuss PRP, RF micondeeling, and other advances in patient care with host Joel L. Cohen, MD.DermWireTV: Galderma Gets Cheeky, COVID Vax & Skin, AKN Classification
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-galderma-gets-cheeky-covid-vax-skin-akn-classification/19955/Only a small percentage of patients have skin reactions to COVID-19 vaccines, but true allergic reactions must be identified. FDA approves Restylane Contour from Galderma. New classification may aid treatment selection or acne keloidalis.Scientifically Speaking: New Directions in Acne Management, Part 2
https://practicaldermatology.com/videos/scientifically-speaking/scientifically-speaking-new-directions-in-acne-management-part-2/19950/From the optimal, safe use of isotretinoin to the proper role for systemic antibiotics and beyond, there are multiple areas of systemic acne care that deserve attention. In the second of a 2-part series, host Joel L. Cohen, MD talks to Diane Berson, MD; Linda Stein Gold, MD; and Emil Tanghetti,Conversations in Acne, Part 3
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-3/19877/What do we know about the anti-inflammatory effects of antibiotics? How can we reduce risks for creating resistance or affecting the gut microbiome? Host Neal Bhatia, MD leads a conversation on these topics and more with Hilary Baldwin, MD and James Q. Del Rosso, DO.DermWireTV: AAD Virtual Data Highlights, Cynosure Consumer Data
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-aad-virtual-data-highlights-cynosure-consumer-data/19818/The American Academy of Dermatology 2020 VMX Virtual Conference shines a light on fresh data from UCB, Leo Pharma, Lilly and Dermira, and Soliton. Cassiopea reports long-term data for Clascoterone. Zilxi from Menlo and Foamix approved for rosacea. Cynosure reports positive cosmetic consumer outlookActinic Keratosis: Therapy Overview
https://practicaldermatology.com/topics/skin-cancer-photoprotection/actinic-keratosis-therapy-overview/19732/Joel Cohen, MD interviews George Martin, MD about the latest developments in actinic keratosis. Dr. Martin said he is eagerly awaiting regulatory review of tirbanibulin, which showed promising results in clinical trials. The two also discuss practical tips and nuances of using 5FU in practice. *Be s